SeaStar Medical Holding CorpNASDAQ:ICU
- LAST PRICE0.5200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.5300/ 30
- Ask / Lots0.5500/ 12
- Open / Previous Close0.5281 / 0.5200
- Day Range
- 52 Week Range
- Volume271,143
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ICU |
|---|---|---|
| 09:32 ET | 2900 | 0.5281 |
| 09:36 ET | 65881 | 0.52 |
| 09:38 ET | 4834 | 0.510201 |
| 09:39 ET | 1625 | 0.515051 |
| 09:41 ET | 800 | 0.5103 |
| 09:43 ET | 200 | 0.5151 |
| 09:45 ET | 400 | 0.52 |
| 09:48 ET | 1000 | 0.5249 |
| 09:52 ET | 6800 | 0.5201 |
| 09:54 ET | 500 | 0.520001 |
| 09:56 ET | 13235 | 0.512 |
| 09:57 ET | 700 | 0.5136 |
| 09:59 ET | 3099 | 0.5199 |
| 10:01 ET | 200 | 0.528 |
| 10:10 ET | 100 | 0.5251 |
| 10:12 ET | 151 | 0.5251 |
| 10:14 ET | 1545 | 0.5251 |
| 10:19 ET | 14783 | 0.525 |
| 10:24 ET | 279 | 0.52 |
| 10:28 ET | 992 | 0.5101 |
| 10:32 ET | 950 | 0.510301 |
| 10:33 ET | 200 | 0.5254 |
| 10:37 ET | 100 | 0.5112 |
| 10:48 ET | 851 | 0.5112 |
| 10:51 ET | 489 | 0.5112 |
| 10:53 ET | 5059 | 0.5111 |
| 10:57 ET | 3940 | 0.521 |
| 11:06 ET | 100 | 0.5301 |
| 11:08 ET | 5512 | 0.5302 |
| 11:09 ET | 1000 | 0.5301 |
| 11:11 ET | 1500 | 0.5302 |
| 11:13 ET | 1816 | 0.530101 |
| 11:18 ET | 2560 | 0.5302 |
| 11:22 ET | 21738 | 0.53 |
| 11:24 ET | 2199 | 0.521 |
| 11:27 ET | 3500 | 0.5128 |
| 11:33 ET | 150 | 0.520999 |
| 11:38 ET | 882 | 0.510591 |
| 11:40 ET | 320 | 0.5101 |
| 11:42 ET | 400 | 0.5102 |
| 11:58 ET | 400 | 0.5101 |
| 12:02 ET | 100 | 0.5102 |
| 12:07 ET | 10214 | 0.524999 |
| 12:12 ET | 100 | 0.5102 |
| 12:16 ET | 500 | 0.524 |
| 12:32 ET | 5000 | 0.524999 |
| 12:38 ET | 1714 | 0.51022 |
| 12:41 ET | 400 | 0.5176 |
| 12:52 ET | 1500 | 0.5103 |
| 12:56 ET | 910 | 0.5102 |
| 01:03 ET | 1046 | 0.5102 |
| 01:26 ET | 115 | 0.511 |
| 01:42 ET | 200 | 0.511 |
| 01:46 ET | 1090 | 0.5137 |
| 01:48 ET | 3199 | 0.525 |
| 01:50 ET | 2200 | 0.5333 |
| 01:55 ET | 1500 | 0.536 |
| 01:57 ET | 500 | 0.5399 |
| 02:00 ET | 854 | 0.5399 |
| 02:08 ET | 200 | 0.53 |
| 02:26 ET | 250 | 0.53 |
| 02:42 ET | 300 | 0.54 |
| 02:44 ET | 2998 | 0.535 |
| 02:49 ET | 100 | 0.535 |
| 02:54 ET | 100 | 0.54 |
| 02:58 ET | 100 | 0.539 |
| 03:03 ET | 791 | 0.535 |
| 03:05 ET | 300 | 0.5303 |
| 03:12 ET | 383 | 0.53 |
| 03:25 ET | 2000 | 0.53 |
| 03:34 ET | 2443 | 0.5167 |
| 03:39 ET | 150 | 0.5157 |
| 03:48 ET | 289 | 0.5103 |
| 03:52 ET | 11753 | 0.5377 |
| 03:59 ET | 2410 | 0.52 |
May 18, 2023
Top Premarket Gainers, from 7:45AM ET on Thursday May 18, 2023 by MT Newswires
7:45AM ET on Thursday May 18, 2023 by MT Newswires
May 15, 2023
BRIEF-Seastar Medical Reports First Quarter 2023 Financial Results And Provides A Business Update, from 5:46PM ET on Monday May 15, 2023 by Thomson Reuters
5:46PM ET on Monday May 15, 2023 by Thomson Reuters
May 10, 2023
Sector Update: Health Care Stocks Advancing Late Wednesday, from 3:55PM ET on Wednesday May 10, 2023 by MT Newswires
3:55PM ET on Wednesday May 10, 2023 by MT NewswiresTop Midday Decliners, from 2:20PM ET on Wednesday May 10, 2023 by MT Newswires
2:20PM ET on Wednesday May 10, 2023 by MT NewswiresSector Update: Health Care Stocks Slipping Wednesday Afternoon, from 2:04PM ET on Wednesday May 10, 2023 by MT Newswires
2:04PM ET on Wednesday May 10, 2023 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SeaStar Medical Holding Corp | 7.1M | -0.2x | --- |
Therapeutic Solutions International Inc | 7.9M | -2.2x | --- |
Nanovibronix Inc | 6.5M | -1.1x | --- |
Omnia Wellness Inc | 5.8M | -1.2x | --- |
Sigyn Therapeutics Inc | 4.9M | -1.1x | --- |
SINTX Technologies Inc | 5.8M | 0.0x | --- |
Company Information
SeaStar Medical Holding Corporation is a medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It uses its proprietary Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.
Contact Information
- Headquarters
- 3513 Brighton Blvd, Suite 410DENVER, CO, United States 80216
- Phone
- 813-362-6488
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Barnett
- Chief Executive Officer, Director
- Eric Schlorff
- Interim Chief Financial Officer
- Caryl Baron
- Chief Medical Officer
- Kevin Chung
- Independent Director
- Allan Collins
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 13.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.13 |
Book Value | $-0.65 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
